I don't know much about psilocybin, and I'll admit I was initially underwhelmed by this post TH announcement (was so sure that it was going to be dealers licence related) but your informative posts have certainly educated me and other holders.
To now have one of the largest psilocybin inventories in Canada, with enough to take us through the extensive Phase 2 and P3 of the Halucenex trials really re-risks this major acquisition.
From what I can read online, other global trials in use of psilocybin for treatment of mental health issues have been very successful.
@MentalAs shared a great article, well worth a read
https://www.cnbc.com/2021/05/11/kevin-oleary-psychedelic-drugs-far-exceed-cannabis-potential.html
Now very content with the Halucenex acquisition, certainly opens up a massive new market for CPH. For the doubters - this is why we pay top dollar for strategic advisors like Bruce Linton.
Onwards and upwards CPH fans!
- Forums
- ASX - By Stock
- CPH
- Ann: Halucenex Secures Additional Pharmaceutical Grade Psilocybin
Ann: Halucenex Secures Additional Pharmaceutical Grade Psilocybin, page-104
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CPH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online